{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:03:06Z","timestamp":1792458186222,"version":"4.5.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007311","name":"Deutsche Kinderkrebsstiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007311","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2019.00435","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T06:00:26Z","timestamp":1571983226000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Haematopoietic Stem Cell Transplantation for Primary Haemophagocytic Lymphohistiocytosis"],"prefix":"10.3389","volume":"7","author":[{"given":"Kai","family":"Lehmberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Moshous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.blre.2014.03.002","article-title":"Hemophagocytic syndromes\u2013an update","volume":"28","author":"Janka","year":"2014","journal-title":"Blood Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.jaci.2018.10.068","article-title":"IFN-gamma and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis","volume":"143","author":"Humblet-Baron","year":"2019","journal-title":"J Allergy Clin Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3324\/haematol.2014.121608","article-title":"The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis","volume":"100","author":"Bode","year":"2015","journal-title":"Haematologica."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e743","DOI":"10.1542\/peds.2005-1789","article-title":"Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients","volume":"117","author":"Ouachee-Chardin","year":"2006","journal-title":"Pediatrics."},{"key":"B5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1365-2141.2005.05501.x","article-title":"Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis","volume":"129","author":"Horne","year":"2005","journal-title":"Br J Haematol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1182\/blood-2011-06-356261","article-title":"Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol","volume":"118","author":"Trottestam","year":"2011","journal-title":"Blood."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1182\/blood-2017-06-788349","article-title":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study","volume":"130","author":"Bergsten","year":"2017","journal-title":"Blood."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e622","DOI":"10.1542\/peds.2006-3164","article-title":"Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients","volume":"120","author":"Mahlaoui","year":"2007","journal-title":"Pediatrics."},{"key":"B9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/pbc.24188","article-title":"Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab","volume":"60","author":"Marsh","year":"2013","journal-title":"Pediatr Blood Cancer."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1182\/blood-2015-12-684399","article-title":"Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis","volume":"127","author":"Das","year":"2016","journal-title":"Blood."},{"key":"B11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1182\/blood-2016-02-700013","article-title":"Therapeutic effect of JAK1\/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice","volume":"128","author":"Maschalidi","year":"2016","journal-title":"Blood."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1182\/bloodadvances.2017007526","article-title":"Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis","volume":"1","author":"Broglie","year":"2017","journal-title":"Blood Adv."},{"key":"B13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.hemonc.2017.07.002","article-title":"Ruxolitinib for secondary hemophagocytic lymphohistiocytosis: First case report","volume":"12","author":"Sin","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"B14","doi-asserted-by":"publisher","first-page":"E47","DOI":"10.1002\/ajh.24971","article-title":"Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: a single patient experience","volume":"93","author":"Slostad","year":"2018","journal-title":"Am J Hematol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/emmm.200900009","article-title":"Neutralization of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice","volume":"1","author":"Pachlopnik Schmid","year":"2009","journal-title":"EMBO Mol Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood."},{"key":"B17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/bmt.2008.133","article-title":"Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis","volume":"42","author":"Baker","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1182\/blood-2010-01-256099","article-title":"XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease","volume":"116","author":"Marsh","year":"2010","journal-title":"Blood."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1182\/blood-2005-05-1819","article-title":"Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis","volume":"107","author":"Cooper","year":"2006","journal-title":"Blood."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.jaci.2016.01.053","article-title":"Effect of stem cell source on long-term chimerism and event-free survival in children with primary immunodeficiency disorders after fludarabine and melphalan conditioning regimen","volume":"138","author":"Rao","year":"2016","journal-title":"J Allergy Clin Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3324\/haematol.2013.094730","article-title":"Treosulfan-based conditioning regimen for children and adolescents with hemophagocytic lymphohistiocytosis","volume":"99","author":"Lehmberg","year":"2014","journal-title":"Haematologica."},{"key":"B22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.bbmt.2017.11.009","article-title":"Treosulfan and fludarabine conditioning for hematopoietic stem cell transplantation in children with primary immunodeficiency: UK experience","volume":"24","author":"Slatter","year":"2018","journal-title":"Biol Blood Marrow Transplant."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.bbmt.2018.01.022","article-title":"Outcomes of children with hemophagocytic lymphohistiocytosis given allogeneic hematopoietic stem cell transplantation in Italy","volume":"24","author":"Messina","year":"2018","journal-title":"Biol Blood Marrow Transplant."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/bmt.2015.171","article-title":"Treosulfan-based conditioning regimens for allogeneic haematopoietic stem cell transplantation in children with non-malignant diseases","volume":"50","author":"Slatter","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5824","DOI":"10.1182\/blood-2010-04-282392","article-title":"Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation","volume":"116","author":"Marsh","year":"2010","journal-title":"Blood."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1182\/blood-2018-01-828277","article-title":"Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies","volume":"132","author":"Allen","year":"2018","journal-title":"Blood."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1002\/pbc.25113","article-title":"Mixed chimerism and graft loss in pediatric recipients of an alemtuzumab-based reduced-intensity conditioning regimen for non-malignant disease","volume":"61","author":"Oshrine","year":"2014","journal-title":"Pediatr Blood Cancer."},{"key":"B28","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1038\/bmt.2008.283","article-title":"The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis","volume":"42","author":"Cooper","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"B29","article-title":"Risk factors for mixed chimerism after treosulfan or melphalan based stem cell transplantation in children with primary hemophagocytic lymphohistiocytosis","volume-title":"35 Annual Meeting of the Histiocyte Society","author":"Wustrau","year":"2019"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1182\/blood-2015-12-684498","article-title":"The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis","volume":"127","author":"Hartz","year":"2016","journal-title":"Blood."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.bbmt.2015.04.009","article-title":"Experience with alemtuzumab, fludarabine, and melphalan reduced-intensity conditioning hematopoietic cell transplantation in patients with nonmalignant diseases reveals good outcomes and that the risk of mixed chimerism depends on underlying disease, stem cell source, and alemtuzumab regimen","volume":"21","author":"Marsh","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"B32","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/bjh.15642","article-title":"Risk factors affecting outcome of unrelated cord blood transplantation for children with familial haemophagocytic lymphohistiocytosis","volume":"184","author":"Furtado-Silva","year":"2019","journal-title":"Br J Haematol."},{"key":"B33","unstructured":"Guidelines for Hematopoietic Stem Cell Transplantation for Primary Immunodeficiencies.2017"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.bbmt.2019.03.009","article-title":"Haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for primary immunodeficiencies and inherited disorders in children","volume":"25","author":"Neven","year":"2019","journal-title":"Biol Blood Marrow Transplant."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1182\/blood-2018-01-827485","article-title":"Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis","volume":"132","author":"Lucchini","year":"2018","journal-title":"Blood."},{"key":"B36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1182\/blood-2009-02-207845","article-title":"Hematopoietic stem cell transplantation in Griscelli syndrome type 2: a single-center report on 10 patients","volume":"114","author":"Pachlopnik Schmid","year":"2009","journal-title":"Blood."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/bmt.2009.358","article-title":"Hematopoietic SCT in children with Griscelli syndrome: a single-center experience","volume":"45","author":"Al-Ahmari","year":"2010","journal-title":"Bone Marrow Transplant."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e13040","DOI":"10.1111\/petr.13040","article-title":"Hematopoietic stem cell transplantation in children with Griscelli syndrome: a single-center experience","volume":"21","author":"Kuskonmaz","year":"2017","journal-title":"Pediatr Transplant."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/pbc.24637","article-title":"Clinical characteristics and outcomes of chediak-Higashi syndrome: a nationwide survey of Japan","volume":"60","author":"Nagai","year":"2013","journal-title":"Pediatr Blood Cancer."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1182\/blood-2012-10-463166","article-title":"The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2","volume":"121","author":"Jessen","year":"2013","journal-title":"Blood."},{"key":"B41","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1182\/blood-2012-06-432500","article-title":"Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes","volume":"121","author":"Marsh","year":"2013","journal-title":"Blood."},{"key":"B42","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/eji.201847818","article-title":"XIAP deficiency in hematopoietic recipient cells drives donor T-cell activation and GvHD in mice","volume":"49","author":"Muller","year":"2019","journal-title":"Eur J Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jcmgh.2018.08.001","article-title":"Dynamic formation of microvillus inclusions during enterocyte differentiation in Munc18-2-deficient intestinal organoids","volume":"6","author":"Mosa","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e94564","DOI":"10.1172\/jci.insight.94564","article-title":"Disrupted apical exocytosis of cargo vesicles causes enteropathy in FHL5 patients with Munc18-2 mutations","volume":"2","author":"Vogel","year":"2017","journal-title":"JCI Insight."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/pbc.24475","article-title":"Persistent defective membrane trafficking in epithelial cells of patients with familial hemophagocytic lymphohistiocytosis type 5 due to STXBP2\/MUNC18-2 mutations","volume":"60","author":"Stepensky","year":"2013","journal-title":"Pediatr Blood Cancer."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11940-017-0439-4","article-title":"How to treat involvement of the central nervous system in hemophagocytic lymphohistiocytosis?","volume":"19","author":"Horne","year":"2017","journal-title":"Curr Treat Options Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e560","DOI":"10.1212\/NXI.0000000000000560","article-title":"Pediatric CNS-isolated hemophagocytic lymphohistiocytosis","volume":"6","author":"Benson","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B48","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.jaci.2017.11.050","article-title":"T-cell gene therapy for perforin deficiency corrects cytotoxicity defects and prevents hemophagocytic lymphohistiocytosis manifestations","volume":"142","author":"Ghosh","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/mt.2014.242","article-title":"Perforin gene transfer into hematopoietic stem cells improves immune dysregulation in murine models of perforin deficiency","volume":"23","author":"Carmo","year":"2015","journal-title":"Mol Ther."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1182\/bloodadvances.2017012088","article-title":"Gene transfer into hematopoietic stem cells reduces HLH manifestations in a murine model of Munc13-4 deficiency","volume":"1","author":"Soheili","year":"2017","journal-title":"Blood Adv."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1182\/blood-2016-07-729871","article-title":"Gene-corrected human Munc13-4-deficient CD8+ T cells can efficiently restrict EBV-driven lymphoproliferation in immunodeficient mice","volume":"128","author":"Soheili","year":"2016","journal-title":"Blood."},{"key":"B52","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1089\/hum.2019.025","article-title":"Retroviral UNC13D gene transfer restores cytotoxic activity of T cells derived from familial hemophagocytic lymphohistiocytosis Type 3 patients in vitro","volume":"30","author":"Dettmer","year":"2019","journal-title":"Hum Gene Ther."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1182\/blood-2012-07-445858","article-title":"SAP gene transfer restores cellular and humoral immune function in a murine model of X-linked lymphoproliferative disease","volume":"121","author":"Rivat","year":"2013","journal-title":"Blood."},{"key":"B54","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jaci.2018.02.053","article-title":"Transfer of gene-corrected T cells corrects humoral and cytotoxic defects in patients with X-linked lymphoproliferative disease","volume":"142","author":"Panchal","year":"2018","journal-title":"J Allergy Clin Immunol."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00435\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T06:00:29Z","timestamp":1571983229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00435\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":54,"alternative-id":["10.3389\/fped.2019.00435"],"URL":"https:\/\/doi.org\/10.3389\/fped.2019.00435","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,25]]},"article-number":"435"}}